Synthesis of micheliolide derivatives and their activities against AML progenitor cells

Molecules

Volumn 18, Issue 5, 2013, Pages 5980-5992

  Ma, Wei Wei ^a   Shi, Qian Qian ^b   Ding, Ya Hui ^c   Long, Jing ^a   Zhang, Quan ^a   Chen, Yue ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Accendatech Co Ltd   (China)

Author keywords

Deriviative; KG 1a; Leukemia progenitor cell; Micheliolide; Synthesis

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; MICHELIOLIDE; SESQUITERPENE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER STEM CELL; CELL STRAIN HL 60; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; SYNTHESIS;

ANTINEOPLASTIC AGENTS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; NEOPLASTIC STEM CELLS; SESQUITERPENES, GUAIANE;

EID: 84878273883     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18055980     Document Type: Article

References (21)

1. Barth, B.M.; Altinoǧlu, E.I.; Shanmugavelandy, S.S.; Kaiser, J.M.; Crespo-Gonzalez, D.; DiVittore, N.A.; McGovern, C.; Goff, T.M.; Keasey, N.R.; Adair, J.H.; et al. Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia. ACS Nano 2011, 5, 5325-5327.
2. Bonnet, D.; Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3, 730-737. (Pubitemid 27298715)
3. Blair, A.; Hogge, D.E.; Sutherland, H. J. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34+/CD71-/HLA-DR-. Blood 1998, 92, 4325-4335. (Pubitemid 28544350)
4. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M.A.; Dick, J.E. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994, 367, 645-648. (Pubitemid 24067706)
5. She, M.; Niu, X.; Chen, X.; Li, J.; Zhou, M.; He, Y.; Le, Y.; Guo, K. Resistance of leukemic stem-cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity. Cancer Lett. 2012, 318. 173-179.
6. Jawad, M.; Seedhouse, C.; Mony, U.; Grundy, M.; Russell, N.H.; Pallis, M. Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia sensitivity to mylotarg by stem cells in AML. Leukemia 2010, 24, 74-80.
7. Guzman, M.L.; Rossi, R.M.; Karnischky, L.; Li, X.; Peterson, D.R.; Howard, D.S.; Jordan, C.T. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005, 105, 4163-4169. (Pubitemid 40720758)
8. Guzman, M.L.; Rossi, R.M.; Neelakantan, S.; Li, X.; Corbett, C.A.; Hassane, D.C.; Becker, M.W.; Bennett, J.M.; Sullivan, E.; Lachowicz, J.L.; et al. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 2007, 110, 4427-4435. (Pubitemid 351377809)
9. Neelakantan, S.; Nasim, S.; Guzman, M.L.; Jordan, C.T.; Crooks, P.A. Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1). Bioorg. Med. Chem. Lett. 2009, 19, 4346-4349.
10. Kevin, P. New agents for the treatment of leukemia: Discovery of DMAPT (LC-1). Drug Discov. Today 2010, 15, 322.
11. Zhang, Q.; Lu, Y.; Ding, Y.; Zhai, J.; Ji, Q.; Ma, W.; Yang, M.; Fan, H.; Long, J.; Tong, Z.; et al. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J. Med. Chem. 2012, 55, 8757-8769.
12. Schall, A.; Reiser, O. Synthesis of biologically active guaianolides with a trans-annulated lactone moiety. Eur. J. Org. Chem. 2008, 2008, 2353-2364.
13. Ogura, M.; Cordell, G.A.; Farnsworth, N.R. Anticancer sesquiterpene lactones of Michelia compressa (magnoliaceae). Phytochemistry 1978, 17, 957-961.
14. Jacobsson, U.; Kumar, V.; Saminathan, S. Sesquiterpene lactones from Michelia champaca. Phytochemistry 1995, 39, 839-843.
15. Zhai, J.-D.; Li, D.; Long, J.; Zhang, H.-L.; Lin, J.-P.; Qiu, C.-J.; Zhang, Q.; Chen, Y. Biomimetic semisynthesis of arglabin from parthenolide. J. Org. Chem. 2012, 77, 7103-7107.
16. Kupchan, S.M.; Eakin, M.A.; Thomas, A.M. Tumor inhibitors. 69. Structure-cytotoxicity relations among the sesquiterpene lactones. J. Med. Chem. 1971, 14, 1147-1152.
17. Lee, K.-H.; Meck, R.; Piantadosi, C.; Huang, E.-S. Antitumor agents. 4. Cytotoxicity and in vivo activity of helenalin esters and related derivatives. J. Med. Chem. 1973, 16, 299-301.
18. Zhao, H.; Pendri, A.; Greenwald, R.B. General procedure for acylation of 3° alcohols: Scandium triflate/DMAP reagent. J. Org. Chem. 1998, 63, 7559-7562. (Pubitemid 128722993)
19. Banker, D.E.; Cooper, J.J.; Fennell, D.A.; Willman, C.L.; Appelbaum, F.R.; Cotter, F.E. PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism. Leukemia Res. 2002, 26, 91-106. (Pubitemid 33085505)
20. Soligo, D.; Servida, F.; Delia, D.; Fontanella, E.; Lamorte, G.; Caneva, L.; Fumiatti, R.; Deliliers, G.L. The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI. Br. J. Haematol. 2001. 113, 126-135. (Pubitemid 32423313)
21. Bailly, J.D.; Muller, C.; Jaffrézou, J.P.; Demur, C.; Gassar, G.; Bordier, C.; Laurent, G. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines. Leukemia 1995, 9, 799-807.